Skip to content

Optimizing exercise training for chronic non-specific low back pain: a pilot randomized controlled trial.

Optimizing exercise training for chronic non-specific low back pain: a pilot randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036674
Enrollment
50
Registered
2025-05-16
Start date
2025-06-24
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-specific low back pain M54.5

Interventions

Group 1: Participants in both exercise groups will follow similar exercise components (stabilization and resistance training) with different frequency protocols. Over the course of six weeks, particip

Sponsors

Hochschule Bochum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: average pain intensity of at least 40 on the Visual Analog Scale

Exclusion criteria

Exclusion criteria: - Actively participating in moderate-vigorous exercises for more than 150 minutes per week - Currently receiving or have undertaken physiotherapy or exercise treatment for low back pain in the previous month - Unable to attend three training sessions per week and four testing sessions over the course of 12 weeks - Specific or radicular syndrome low back pain - Inability to communicate in English - Current pregnancy - Less than one-year post-partum - Current clinical diagnosis of severe depression, acute anxiety disorders, schizophrenia, or other severe mental health conditions - Stroke - Traumatic brain injury - Other absolute contraindications to exercise training - Unable to provide informed consent (e.g. cognitive impairment)

Design outcomes

Primary

MeasureTime frame
Disability (Oswestry Disability Index, ODI 2.1b) [Baseline, 3-week post-baseline, 6-week post-baseline (primary endpoint), 12-week post-baseline] Low back pain intensity (Visual Analogue Scale, VAS 0-100): a) current pain intensity, b) average pain this week, c) worst pain today and d) worst pain intensity in the last week [Baseline, end of each week, 6-week post-baseline (primary endpoint), 12-week post-baseline]

Secondary

MeasureTime frame
Fear-avoidance beliefs (Fear avoidance beliefs questionnaire, FABQ) [Baseline, 6-week post-baseline (primary endpoint), 12-week post-baseline] Health-related Quality of life (EuroQol-5 Dimensions-5 Levels questionnaire, EQ-5D-5L) [Baseline, 6-week post-baseline (primary endpoint), 12-week post-baseline] Weekly physical activity [International Physical Activity Questionnaire-short form, metabolic equivalent minutes per week] [Baseline] Feasibility measures: Safety (Number and categories of adverse events) [Continuously monitored during the 6-week intervention period] i. Intervention-related adverse events: Adverse events occurring during supervised exercise sessions and home-exercise sessions ii. Adverse events unrelated to the study intervention All adverse events will be recorded and classified according to the following criteria: a. Causality: all-cause adverse events or exercise-related adverse events b. Severity: whether mild, moderate or severe; required hospitalization or medical intervention c. Outcomes: recovery, ongoing symptoms, death d. Temporal association: time taken to occurrence of adverse events e. Type: musculoskeletal, cardiovascular, respiratory or other Adherence and attrition rates: frequency of session attendance and reasons for non-attendance. Intervention acceptability (expectations and satisfaction) Expectations related to the exercise intervention [Baseline, 6-week post-baseline (primary endpoint)] will be rated on a 1–5 scale for a 20-point (out of 100) pain relief, with 1 indicating ‘not at all likely’ and 5 indicating ‘extremely likely.’ Upon completion of treatment intervention, participants will rate whether their expectations were met on a 1-5 scale, where 1 indicates ‘definitely not’ and 5 indicates ‘definitely yes’. Clinical meaningfulness (number of clinical and home exercise sessions needed for a meaningful pain relief) [Baseline and 6-week post-baseline (primary endpoint] Satisfaction with the exercise dos

Countries

Germany

Contacts

Public ContactNitin Kumar Arora

Hochschule Bochum

nitin.arora@hs-bochum.de+49 234 77727-779

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026